Nifty

:

23349.90

Sensex

:

77155.79

-168.60 (-0.72%)
-422.59 (-0.54%)

Login

Nifty
Sensex

:
:

23349.90
77155.79

-168.60 (-0.72%)
-422.59 (-0.54%)

Mangalam Drugs And Organics Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 532637 | NSE: MANGALAM

Watchlist

NSE BSE

113.32

05-Jul-2024

Open
High
Low
Previous Close

109.00
114.20
106.70
108.57

Volume
Traded Value (lacs)
52 Week High
52 Week Low

179196
199.57
144.99
90.80

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

165.88
52.28
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

259.79
N/A
1.14

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

5.27
5.48
-6.51

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-1.56
-6.00
-18.73

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

10.17
9.14
11.94

P:BV (Average)

8 Years
5 Years
3 Years

1.37
1.37
1.27

EV:EBITDA (Average)

8 Years
5 Years
3 Years

9.62
11.07
13.98

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 76.54 87.47 -12.50% 102.24 91.11 12.22% 97.34 63.33 53.70% 81.56 108.33 -24.71%
Expenses 68.35 90.94 -24.84% 90.53 90.86 -0.36% 90.36 56.86 58.92% 79.36 99.89 -20.55%
EBITDA 8.19 -3.47 - 11.70 0.24 4,775.00% 6.98 6.47 7.88% 2.19 8.43 -74.02%
EBIDTM 10.70% -3.97% 11.45% 0.27% 7.17% 10.22% 2.69% 7.78%
Other Income 0.02 0.02 0.00% 0.05 0.29 -82.76% 0.00 0.14 -100.00% 0.03 0.00 0
Interest 3.75 3.41 9.97% 3.95 3.43 15.16% 3.31 3.22 2.80% 3.25 2.56 26.95%
Depreciation 3.87 3.42 13.16% 3.86 2.75 40.36% 3.62 2.88 25.69% 3.73 2.76 35.14%
PBT 0.59 -10.29 - 3.94 -5.65 - 0.04 0.50 -92.00% -4.75 3.12 -
Tax -2.10 -0.75 - 0.39 -1.26 - -0.46 0.08 - -1.19 0.90 -
PAT 2.69 -9.54 - 3.55 -4.39 - 0.50 0.43 16.28% -3.56 2.23 -
PATM 3.51% -10.90% 3.47% -4.82% 0.51% 0.67% -4.36% 2.06%
EPS 1.70 -6.03 - 2.24 -2.78 - 0.32 0.27 18.52% -2.25 1.41 -

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 76.54 0.00 0 102.24 0.00 0 97.34 0.00 0 0.00 0.00 0
Expenses 68.34 0.00 0 90.54 0.00 0 90.36 0.00 0 0.00 0.00 0
EBITDA 8.19 0.00 0 11.70 0.00 0 6.98 0.00 0 0.00 0.00 0
EBIDTM 10.70% 0.00% 11.44% 0.00% 7.17% 0.00% 0.00% 0.00%
Other Income 0.02 0.00 0 0.05 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 3.75 0.00 0 3.95 0.00 0 3.31 0.00 0 0.00 0.00 0
Depreciation 3.88 0.00 0 3.86 0.00 0 3.63 0.00 0 0.00 0.00 0
PBT 0.59 0.00 0 3.93 0.00 0 0.04 0.00 0 0.00 0.00 0
Tax -2.10 0.00 - 0.40 0.00 0 -0.46 0.00 - 0.00 0.00 0
PAT 2.69 0.00 0 3.53 0.00 0 0.50 0.00 0 0.00 0.00 0
PATM 3.51% 0.00% 3.45% 0.00% 0.51% 0.00% 0.00% 0.00%
EPS 1.70 0.00 0 2.23 0.00 0 0.31 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 357.68 368.59 372.25 451.07 384.70 282.35 227.58 279.38 302.89 295.02 220.58 Net Sales Growth 2.12% -0.98% -17.47% 17.25% 36.25% 24.07% -18.54% -7.76% 2.67% 33.75% Cost Of Goods Sold 219.06 244.51 250.44 306.64 251.96 195.35 153.61 166.76 195.93 203.92 157.25 Gross Profit 138.62 124.08 121.81 144.43 132.74 87.01 73.97 112.61 106.95 91.10 63.33 GP Margin 38.75% 33.66% 32.72% 32.02% 34.50% 30.82% 32.50% 40.31% 35.31% 30.88% 28.71% Total Expenditure 328.60 351.20 346.53 402.01 326.68 258.66 217.90 232.53 256.97 257.50 200.23 Power & Fuel Cost - 28.50 25.59 22.90 16.12 14.24 14.56 14.31 11.53 10.90 11.90 % Of Sales - 7.73% 6.87% 5.08% 4.19% 5.04% 6.40% 5.12% 3.81% 3.69% 5.39% Employee Cost - 39.07 34.61 37.25 29.88 26.04 25.82 22.98 19.08 14.39 10.91 % Of Sales - 10.60% 9.30% 8.26% 7.77% 9.22% 11.35% 8.23% 6.30% 4.88% 4.95% Manufacturing Exp. - 21.80 19.74 19.08 14.05 9.77 12.04 14.84 11.49 11.48 9.07 % Of Sales - 5.91% 5.30% 4.23% 3.65% 3.46% 5.29% 5.31% 3.79% 3.89% 4.11% General & Admin Exp. - 6.17 5.41 6.10 6.05 6.67 7.59 7.54 6.36 4.55 2.51 % Of Sales - 1.67% 1.45% 1.35% 1.57% 2.36% 3.34% 2.70% 2.10% 1.54% 1.14% Selling & Distn. Exp. - 6.93 6.19 7.82 7.61 5.16 3.96 5.58 9.21 9.83 8.14 % Of Sales - 1.88% 1.66% 1.73% 1.98% 1.83% 1.74% 2.00% 3.04% 3.33% 3.69% Miscellaneous Exp. - 4.21 4.55 2.22 1.01 1.42 0.32 0.51 3.36 2.43 8.14 % Of Sales - 1.14% 1.22% 0.49% 0.26% 0.50% 0.14% 0.18% 1.11% 0.82% 0.20% EBITDA 29.06 17.39 25.72 49.06 58.02 23.69 9.68 46.85 45.92 37.52 20.35 EBITDA Margin 8.12% 4.72% 6.91% 10.88% 15.08% 8.39% 4.25% 16.77% 15.16% 12.72% 9.23% Other Income 0.10 0.10 0.44 0.09 0.00 1.18 0.32 0.84 0.31 0.20 0.09 Interest 14.26 13.92 12.96 11.16 9.33 10.40 8.65 11.78 10.04 9.29 10.28 Depreciation 15.08 14.63 10.99 10.25 9.18 8.22 7.09 6.57 5.01 4.41 4.15 PBT -0.18 -11.06 2.21 27.73 39.52 6.25 -5.74 29.35 31.18 24.02 6.01 Tax -3.36 -2.01 0.94 8.08 11.55 -2.00 2.29 9.46 8.91 7.98 -0.13 Tax Rate 1,866.67% 18.17% 42.53% 29.14% 29.23% -32.00% -39.90% 32.23% 28.58% 33.22% -2.16% PAT 3.18 -9.05 1.27 19.66 27.97 8.25 -8.03 19.89 22.27 16.03 6.14 PAT before Minority Interest 3.18 -9.05 1.27 19.66 27.97 8.25 -8.03 19.89 22.27 16.03 6.14 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 0.89% -2.46% 0.34% 4.36% 7.27% 2.92% -3.53% 7.12% 7.35% 5.43% 2.78% PAT Growth 128.22% - -93.54% -29.71% 239.03% - - -10.69% 38.93% 161.07% EPS 2.01 -5.73 0.80 12.44 17.70 5.22 -5.08 12.59 14.09 10.15 3.89

Description TTM Mar 24
Net Sales - 368.59 Net Sales Growth - Cost Of Goods Sold - 244.51 Gross Profit - 124.08 GP Margin - 33.66% Total Expenditure - 351.20 Power & Fuel Cost - 28.50 % Of Sales - 7.73% Employee Cost - 39.07 % Of Sales - 10.60% Manufacturing Exp. - 21.80 % Of Sales - 5.91% General & Admin Exp. - 6.15 % Of Sales - 1.67% Selling & Distn. Exp. - 6.93 % Of Sales - 1.88% Miscellaneous Exp. - 4.22 % Of Sales - 1.14% EBITDA - 17.39 EBITDA Margin - 4.72% Other Income - 0.10 Interest - 13.92 Depreciation - 14.65 PBT - -11.07 Tax - -2.00 Tax Rate - 18.07% PAT - -9.07 PAT before Minority Interest - -9.07 Minority Interest - 0.00 PAT Margin - -2.46% PAT Growth - EPS - -5.74

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 142.35 151.96 150.56 130.79 103.94 95.66 103.77 85.72 61.52 29.36 Share Capital 15.83 15.83 15.83 15.83 15.83 15.83 15.83 15.83 14.38 13.18 Total Reserves 126.52 136.13 134.73 114.96 88.11 79.83 87.94 69.89 38.66 16.19 Non-Current Liabilities 33.85 42.32 47.75 24.25 17.26 24.88 23.18 26.03 25.37 41.10 Secured Loans 12.44 18.77 24.85 6.63 3.91 8.10 10.65 16.85 12.20 18.30 Unsecured Loans 0.91 0.00 0.25 0.25 0.26 0.50 0.50 0.00 4.72 21.10 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 180.95 163.71 130.11 109.08 109.47 90.81 99.84 77.76 72.87 99.43 Trade Payables 83.05 95.43 54.55 43.39 56.59 32.41 37.63 20.78 20.68 54.77 Other Current Liabilities 22.31 17.00 25.20 14.10 10.19 7.30 10.76 14.97 16.82 12.83 Short Term Borrowings 74.60 49.57 47.10 51.18 41.86 50.51 50.75 41.32 35.38 31.82 Short Term Provisions 0.99 1.72 3.27 0.40 0.83 0.59 0.71 0.70 0.00 0.00 Total Liabilities 357.15 357.99 328.42 264.12 230.67 211.35 226.79 189.51 159.76 169.89 Net Block 147.31 142.36 134.96 117.82 101.07 103.49 101.91 92.56 54.19 52.95 Gross Block 260.69 241.40 223.81 196.70 170.92 165.15 156.14 140.26 97.57 91.82 Accumulated Depreciation 113.38 99.04 88.85 78.88 69.85 61.66 54.23 47.70 43.38 38.88 Non Current Assets 157.36 154.72 143.39 130.19 111.49 106.32 103.95 93.72 60.11 53.86 Capital Work in Progress 7.74 9.49 5.71 6.35 1.24 0.20 0.07 0.00 4.93 0.00 Non Current Investment 0.03 0.00 0.00 0.22 0.22 0.24 0.24 0.00 0.00 0.00 Long Term Loans & Adv. 2.29 2.86 2.72 5.79 8.96 2.38 1.73 1.16 0.99 0.91 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 199.78 203.26 185.03 133.92 119.17 105.04 122.84 95.78 99.65 116.04 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.64 0.24 0.24 Inventories 123.64 137.47 117.11 58.59 64.84 73.45 60.13 37.25 47.34 57.34 Sundry Debtors 27.94 46.53 46.49 54.31 39.98 17.63 45.21 36.82 30.14 44.25 Cash & Bank 1.01 1.04 1.95 0.59 1.63 1.43 0.43 0.63 0.50 0.68 Other Current Assets 47.19 1.94 3.79 3.66 12.72 12.53 17.07 19.45 21.43 13.53 Short Term Loans & Adv. 45.50 16.28 15.69 16.77 10.24 10.14 14.59 16.05 21.12 13.23 Net Current Assets 18.83 39.55 54.92 24.84 9.71 14.23 23.00 18.03 26.78 16.61 Total Assets 357.14 357.98 328.42 264.11 230.66 211.36 226.79 189.50 159.76 169.90

Description Mar 24
Shareholder's Funds 135.79 Share Capital 15.83 Total Reserves 119.96 Non-Current Liabilities 33.85 Secured Loans 12.44 Unsecured Loans 0.91 Long Term Provisions 0.00 Current Liabilities 164.06 Trade Payables 66.16 Other Current Liabilities 22.31 Short Term Borrowings 74.60 Short Term Provisions 0.99 Total Liabilities 333.70 Net Block 147.67 Gross Block 261.27 Accumulated Depreciation 113.60 Non Current Assets 157.70 Capital Work in Progress 7.74 Non Current Investment 0.00 Long Term Loans & Adv. 2.29 Other Non Current Assets 0.00 Current Assets 176.00 Current Investments 0.00 Inventories 123.64 Sundry Debtors 27.94 Cash & Bank 1.19 Other Current Assets 23.23 Short Term Loans & Adv. 21.54 Net Current Assets 11.94 Total Assets 333.70

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 12.17 38.08 25.71 27.55 30.55 21.69 24.58 42.80 21.81 13.96 PBT -11.06 2.21 27.73 39.52 6.25 -5.74 29.35 31.18 24.02 6.01 Adjustment 27.81 24.12 22.37 17.24 18.71 16.22 18.30 17.45 13.85 14.50 Changes in Working Capital -4.39 11.72 -15.59 -19.94 5.64 11.21 -16.81 1.50 -12.11 -6.48 Cash after chg. in Working capital 12.36 38.06 34.52 36.82 30.60 21.69 30.83 50.13 25.76 14.03 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.19 0.03 -8.81 -9.27 -0.05 0.00 -6.26 -7.33 -3.95 -0.07 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -17.91 -22.17 -27.33 -31.29 -6.87 -9.26 -15.95 -39.45 -10.88 -3.84 Net Fixed Assets -17.54 -21.37 -26.47 -30.89 -6.81 -9.14 -15.95 -37.76 -10.68 -3.54 Net Investments -0.03 0.00 0.22 0.00 0.02 0.00 1.40 -1.40 0.00 -0.06 Others -0.34 -0.80 -1.08 -0.40 -0.08 -0.12 -1.40 -0.29 -0.20 -0.24 Cash from Financing Activity 5.70 -16.82 2.98 2.70 -23.48 -11.43 -8.82 -3.22 -11.11 -9.54 Net Cash Inflow / Outflow -0.04 -0.91 1.36 -1.04 0.20 1.00 -0.20 0.13 -0.18 0.58 Opening Cash & Equivalents 1.04 1.95 0.58 1.62 1.43 0.43 0.63 0.50 0.68 0.10 Closing Cash & Equivalent 1.00 1.04 1.95 0.58 1.63 1.43 0.43 0.63 0.50 0.68

Description Mar 24
Cash From Operating Activity 3.91 PBT 3.97 Adjustment 13.95 Changes in Working Capital -13.91 Cash after chg. in Working capital 4.00 Interest Paid 0.00 Tax Paid -0.09 Other Direct Exp. Paid 0.00 Extra & Other Items 0.00 Cash From Investing Activity -11.83 Net Fixed Assets Net Investments Others Cash from Financing Activity 5.23 Net Cash Inflow / Outflow -2.69 Opening Cash & Equivalents 3.87 Closing Cash & Equivalent 1.18

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 89.93 96.00 95.12 82.63 65.67 60.44 65.56 54.15 36.89 22.28 ROA -2.53% 0.37% 6.64% 11.31% 3.73% -3.67% 9.56% 12.76% 9.73% 4.16% ROE -6.15% 0.84% 13.97% 23.83% 8.27% -8.05% 20.99% 32.11% 38.91% 23.36% ROCE 1.23% 6.65% 18.34% 28.01% 10.66% 1.76% 25.35% 30.18% 29.14% 15.69% Fixed Asset Turnover 1.47 1.60 2.15 2.09 1.86 1.61 2.08 2.63 3.20 2.50 Receivable days 36.88 45.61 40.78 44.73 33.58 44.31 48.65 39.11 44.78 59.90 Inventory Days 129.28 124.81 71.08 58.56 80.60 94.20 57.76 49.41 63.02 76.02 Payable days 133.22 109.29 58.29 72.42 66.80 55.04 44.26 30.96 51.61 68.98 Cash Conversion Cycle 32.94 61.12 53.58 30.86 47.38 83.47 62.15 57.56 56.19 66.94 Total Debt/Equity 0.67 0.49 0.52 0.49 0.48 0.66 0.66 0.77 1.13 2.65 Interest Cover 0.21 1.17 3.48 5.24 1.60 0.34 3.49 4.11 3.58 1.58

Description Mar 24
Book Value (Rs.) 85.79 ROA -2.72% ROE -6.68% ROCE 1.23% Fixed Asset Turnover 1.41 Receivable days 27.67 Inventory Days 122.43 Payable days 98.76 Cash Conversion Cycle 51.34 Total Debt/Equity 0.70 Interest Cover 0.20

Top Investors:

ashutosh taparia

jyotiprasad taparia

ambika food industries private limited

Annual Reports:

News Update:

Mangalam Drugs secures grant from MMV for research, development of Pyronaridine
26th Aug 2024, 12:16 PM

The grant will support research and development efforts aimed at improving the technology and efficiency of pyronaridine production
Read More
Mangalam Drugs expanding anti-malaria API portfolio with Pyronaridine
20th Aug 2024, 12:08 PM

It is the second company, following the innovator, to achieve this significant milestone
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback